REVB

Revelation Biosciences, Inc.

2.85 USD
+0.04 (+1.42%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Revelation Biosciences, Inc. stock is down -71.12% since 30 days ago. The next earnings date is Mar 28, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 3 February’s closed higher than January.

About Revelation Biosciences, Inc.

Revelation Biosciences, Inc. focuses on the development or commercialization of innate immune system therapeutics and diagnostics. The company's lead therapeutic candidate is REVTx-99, an anti-viral nasal drop for the prevention or treatment of respiratory viral infections.